Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Omega Therapeutics stock
Learn how to easily invest in Omega Therapeutics stock.
Omega Therapeutics is a biotechnology business based in the US. Omega Therapeutics shares (OMGA) are listed on the NASDAQ and all prices are listed in US Dollars. Omega Therapeutics employs 79 staff and has a trailing 12-month revenue of around $1.5 million.
How to buy Omega Therapeutics stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – OMGA. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Omega Therapeutics stock price (NASDAQ: OMGA)Use our graph to track the performance of OMGA stocks over time.
Omega Therapeutics shares at a glance
|Latest market close||$7.75|
|52-week range||$1.98 - $14.31|
|50-day moving average||$6.37|
|200-day moving average||$4.97|
|Wall St. target price||$15.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.26|
Buy Omega Therapeutics stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Omega Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Omega Therapeutics price performance over time
|1 week (2023-01-19)||12.48%|
|1 month (2022-12-27)||63.16%|
|3 months (2022-10-27)||47.06%|
|6 months (2022-07-27)||40.65%|
|1 year (2022-01-27)||-28.17%|
|2 years (2021-01-23)||N/A|
|3 years (2020-01-23)||N/A|
|5 years (2018-01-23)||N/A|
Omega Therapeutics financials
|Revenue TTM||$1.5 million|
|Gross profit TTM||$-47,721,000|
|Return on assets TTM||-27.96%|
|Return on equity TTM||-52.39%|
|Market capitalisation||$331.1 million|
TTM: trailing 12 months
Omega Therapeutics share dividends
We're not expecting Omega Therapeutics to pay a dividend over the next 12 months.
Omega Therapeutics overview
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, as well as the mechanism that controls gene expression and aspect of an organism's life. The company's platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a range without altering native nucleic acid sequences. Its modular and programmable mRNA medicines, and Omega Epigenomic Controllers are designed to target specific epigenomic loci within insulated genomic domains from genome-wide DNA-sequences with single or multiple genes to treat and cure diseases through Precision Genomic Control. The company is advancing a pipeline of development candidates covering a range of disease areas, including oncology, regenerative medicine, multigenic diseases, and select monogenic diseases. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Omega Therapeutics in the news
Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Frequently asked questionsWhat percentage of Omega Therapeutics is owned by insiders or institutions?
Currently 3.69% of Omega Therapeutics shares are held by insiders and 88.787% by institutions. How many people work for Omega Therapeutics?
Latest data suggests 79 work at Omega Therapeutics. When does the fiscal year end for Omega Therapeutics?
Omega Therapeutics's fiscal year ends in December. Where is Omega Therapeutics based?
Omega Therapeutics's address is: 20 Acorn Park Drive, Cambridge, MA, United States, 02140 What is Omega Therapeutics's ISIN number?
Omega Therapeutics's international securities identification number is: US68217N1054
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert